Good presentation today. Dr van der Weerden provided a good overview of the Pezadeftide "mechanism of action" which impressed me - a lay person. Phase 11 results due to be released this quarter. Phase 1 "maximal use" trial in the middle of the year - a requirement of the FDA. My understanding is a safety-related 4 week trial involving ~20 people with applications of Pezadeftide on the nails and surrounding skin to demonstrate no absorption. Subject to Phase II results (expectations positive), Phase III commences end of CY22 and expected to run 12 months. Discussions regarding Japanese partnership (in that "insular" market) ongoing and positive.
Good presentation today. Dr van der Weerden provided a good...
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add HXL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.9¢ |
Change
0.000(0.00%) |
Mkt cap ! $1.503M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 870244 | 0.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.0¢ | 624826 | 3 |
View Market Depth
| Last trade - 16.12pm 20/06/2024 (20 minute delay) ? |
| HXL (ASX) Chart |
Day chart unavailable